Clinical data management is entering a new phase as AI automates EDC build, shortens timelines, and enables data teams to focus on quality.

The boundaries between clinical care, data science, and tech are fast dissolving, making way for a new blueprint for healthcare education ...

NEEDHAM, MA, UNITED STATES, February 10, 2026 /EINPresswire.com/ — Trialt, a global clinical research organization (CRO) specializing in biostatistics, statistical ...

PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class ...

Phase 1 Data Published in Journal of Opioid Management Validates First-in-Class Overdose-Limiting Opioid Technology of PF614-MPAR ~ SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 /Ensysce Biosciences ...

Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investorsProceeds support the achievement of value inflection points for multiple RNA ...

Several Prisma Health hospitals have been recognized with Women's Choice Awards for clinical performance. Three students from ...

Data access empowerment operating models enable public health leaders to make timely, informed decisions with trusted intelligence and faster insights.

Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9–Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant ...

Phase 1 clinical trial of SL-325 ongoing, with data expected in the second quarter of 2026 -Phase 2 clinical trial of SL-325 in patients with Crohn's disease expected to initiate in the third quarter ...